Age
Item
men or women who are 30 to 75 years of age (inclusive) at study visit 1.
boolean
C0001779 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus disease length
Item
clinical diagnosis of type 2 diabetes (defined according to idf guidelines) for a minimum of 6 months prior to study visit 1
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Medical care Diabetes Mellitus General Practitioner
Item
patients for whom the gp is the primary medical provider of diabetes care and for whom referral to another doctor for diabetes care is not anticipated within 3 months of study visit 1
boolean
C0496675 (UMLS CUI [1,1])
C0011849 (UMLS CUI [1,2])
C0017319 (UMLS CUI [1,3])
Informed Consent
Item
patients who give informed consent to participate.
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria
Item
exclusion criteria
boolean
C0680251 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
patients with type 1 diabetes mellitus
boolean
C0011854 (UMLS CUI [1])
Ketoacidosis Episode of
Item
patients with any previous episode of ketoacidosis
boolean
C0220982 (UMLS CUI [1,1])
C0332189 (UMLS CUI [1,2])
Insulin use chronic Patient need for | Exception Gender Pregnancy
Item
patients who required chronic use (>/= 6 months) of insulin at any time in the past, with the exception of females during pregnancy
boolean
C0240016 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0686904 (UMLS CUI [1,3])
C1705847 (UMLS CUI [2,1])
C0079399 (UMLS CUI [2,2])
C0032961 (UMLS CUI [2,3])
Insulin regime | Exception Insulin regime short-term | Maintenance Glycaemia control Event | Hospitalization | Medical procedure | Intervention | Communicable Disease | Trauma
Item
patients receiving insulin treatment at study visit 1 or within the previous 6 months, with the exception of patients who received short-term treatment (= 7 days) with insulin to maintain glycaemic control for an acute event (e.g. hospitalisation or medical procedure/intervention, infection or trauma).
boolean
C0557978 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0557978 (UMLS CUI [2,2])
C0443303 (UMLS CUI [2,3])
C0024501 (UMLS CUI [3,1])
C3267174 (UMLS CUI [3,2])
C0441471 (UMLS CUI [3,3])
C0019993 (UMLS CUI [4])
C0199171 (UMLS CUI [5])
C0184661 (UMLS CUI [6])
C0009450 (UMLS CUI [7])
C3714660 (UMLS CUI [8])
Glucocorticoid therapy | Exception Topical glucocorticoid | Exception Glucocorticoids Inhaled
Item
treatment with glucocorticoid at study visit 1 or within the previous 6 months, with the exception of topical or inhaled glucocorticoid
boolean
C0744425 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0017712 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0017710 (UMLS CUI [3,2])
C0001559 (UMLS CUI [3,3])
Pregnancy | Pregnancy, Planned | Gender Contraceptive methods Discontinued
Item
females who are pregnant or considering pregnancy or stopping contraception within the course of the study
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C1444662 (UMLS CUI [3,3])
Kidney Failure, Chronic | Glomerular Filtration Rate MDRD formula | Renal Replacement Therapy | Hemodialysis | Peritoneal Dialysis | Kidney Transplantation
Item
patients with end-stage renal disease, defined as glomerular filtration rate (gfr) by the mdrd (modification of diet in renal disease) formula < 15 ml/min/1.73 m2, or on renal replacement therapy with haemodialysis, peritoneal dialysis or renal transplant.
boolean
C0022661 (UMLS CUI [1])
C0017654 (UMLS CUI [2,1])
C3839656 (UMLS CUI [2,2])
C0206074 (UMLS CUI [3])
C0019004 (UMLS CUI [4])
C0031139 (UMLS CUI [5])
C0022671 (UMLS CUI [6])
Mental disorders | Substance Use Disorders | Impaired cognition Interferes with Treatment compliance
Item
patients with psychiatric disease, active drug or alcohol abuse or other cognitive impairment that may interfere with treatment compliance.
boolean
C0004936 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
C0338656 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C1321605 (UMLS CUI [3,3])
Investigational New Drugs
Item
receipt of any investigational drug within 30 days of study visit 1.
boolean
C0013230 (UMLS CUI [1])
Medical care Diabetes Mellitus Endocrinologist | Medical care Diabetes Mellitus General Practitioners | Clinical Trial Eligibility Criteria | Glycosylated hemoglobin A
Item
patients receiving diabetes care from another doctor (specialist endocrinologist, general physician, or another gp) other eligibility criteria considerations the hba1c at entry for newly recruited patients will be monitored centrally. if there is a significant risk that more than 25% of the total study population will have a baseline hba1c </= 6.5%, then recruitment of subsequent patients will be restricted to those with hba1c > 6.5%.
boolean
C0496675 (UMLS CUI [1,1])
C0011849 (UMLS CUI [1,2])
C0259863 (UMLS CUI [1,3])
C0496675 (UMLS CUI [2,1])
C0011849 (UMLS CUI [2,2])
C0017319 (UMLS CUI [2,3])
C1516637 (UMLS CUI [3])
C0019018 (UMLS CUI [4])